Lean mass index, body fat and survival in Chinese patients with coronary artery disease

B-T Huang1, Y Peng1, W Liu1

  • 1From the Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Wuhou District, Chengdu 610041, China.

Insights

In Chinese patients with coronary artery disease (CAD), low lean mass index (LMI) is linked to higher mortality. Higher LMI, not body fat (BF), is associated with improved survival outcomes in this population.

Area of Science:

  • Cardiology
  • Metabolic Health
  • Clinical Research

Background:

  • The 'obesity paradox' is inconsistently observed in Asian populations with coronary artery disease (CAD).
  • Understanding body composition's role in CAD outcomes is crucial for this demographic.

Purpose of the Study:

  • To investigate the association between body composition metrics, specifically body fat (BF) percentage and lean mass index (LMI), and clinical outcomes in Chinese patients diagnosed with CAD.

Main Methods:

  • A cohort study included 3280 patients with angiographically confirmed CAD.
  • Body composition was assessed using the Clínica Universidad de Navarra-Body Adiposity Estimator.
  • Mortality rates were compared across quartiles of LMI.

Main Results:

  • Over a median of 24 months, 288 (8.8%) deaths occurred.
  • Increasing LMI showed a significant inverse association with mortality.
  • Higher quartiles of LMI were independently associated with a survival benefit after multivariable adjustment (Q4 HR 0.58, Q3 HR 0.60, Q2 HR 0.60 vs. Q1 reference).
  • Body fat percentage did not demonstrate a protective effect on survival in univariate analyses.

Conclusions:

  • Low lean mass index (LMI) is a significant predictor of all-cause mortality in Chinese patients with coronary artery disease (CAD).
  • Body fat percentage is not a significant predictor of mortality in this patient group.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
880
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
943
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
642